Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-10

FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA for Amantadine Hydrochloride by Rising Pharma Holdings, Inc., enabling the marketing of the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine hydrochloride (amantadine hydrochloride)

Snippet

SUPPL AP for AMANTADINE HYDROCHLORIDE (AMANTADINE HYDROCHLORIDE)